Intraventricular injection of eravacycline in the treatment of carbapenem-resistant Acinetobacter baumannii meningitis: a case report

被引：0
|
作者：
Liu, Qihui [1 ]
Zhou, Xian [1 ]
Du, Zhuoying [2 ]
Wang, Xuan [1 ]
Li, Ning [1 ]
机构：
[1] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Natl Med Ctr Infect Dis,Dept Infect Dis,Shanghai K, Shanghai 200040, Peoples R China
[2] Fudan Univ, Huashan Hosp, Shanghai Med Coll, Inst Brain Sci,Dept Neurosurg,Natl Key Lab Med Neu, Shanghai, Peoples R China
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2025年
关键词：
IN-VITRO ACTIVITY;
D O I：
10.1093/jac/dkaf069
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] In Vitro Activity of Eravacycline against Carbapenem-Resistant Enterobacteriaceae and Acinetobacter baumannii
    Livermore, David M.
    Mushtaq, Shazad
    Warner, Marina
    Woodford, Neil
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (06) : 3840 - 3844
  • [2] Emergence of eravacycline heteroresistance in carbapenem-resistant Acinetobacter baumannii isolates in China
    Li, Yi-tan
    Chen, Xian-di
    Guo, Ying-yi
    Lin, Shan-wen
    Wang, Ming-zhen
    Xu, Jian-bo
    Wang, Xiao-hu
    He, Guo-hua
    Tan, Xi-xi
    Zhuo, Chao
    Lin, Zhi-wei
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [3] Clinical Outcomes of Eravacycline in Patients Treated Predominately for Carbapenem-Resistant Acinetobacter baumannii
    Alosaimy, Sara
    Morrisette, Taylor
    Lagnf, Abdalhamid M.
    Rojas, Leonor M.
    King, Madeline A.
    Pullinger, Benjamin M.
    Hobbs, Athena L., V
    Perkins, Nicholson B., III
    Veve, Michael P.
    Bouchard, Jeannette
    Gore, Tristan
    Jones, Bruce
    Truong, James
    Andrade, Justin
    Huang, Glen
    Cosimi, Reese
    Kang-Birken, S. Lena
    Molina, Kyle C.
    Biagi, Mark
    Pierce, Michael
    Scipione, Marco R.
    Zhao, Jing J.
    Davis, Susan L.
    Rybak, Michael J.
    MICROBIOLOGY SPECTRUM, 2022, 10 (05):
  • [4] Successful Treatment of Carbapenem-Resistant Acinetobacter baumannii Meningitis With Sulbactam-Durlobactam
    Tamma, Pranita D.
    Immel, Shanan
    Karaba, Sara M.
    Soto, Caitlin L.
    Conzemius, Rick
    Gisriel, Emily
    Tekle, Tsigereda
    Stambaugh, Haley
    Johnson, Emily
    Tornheim, Jeffrey A.
    Simner, Patricia J.
    CLINICAL INFECTIOUS DISEASES, 2024, 79 (04) : 819 - 825
  • [5] Implications of postneurosurgical meningitis caused by carbapenem-resistant Acinetobacter baumannii
    Moon, Chisook
    Kwak, Yee Gyung
    Kim, Baek-Nam
    Kim, Eu Suk
    Lee, Chang-Seop
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2013, 19 (05) : 916 - 919
  • [6] Carbapenem-resistant Acinetobacter baumannii: in pursuit of an effective treatment
    Piperaki, E. -T.
    Tzouvelekis, L. S.
    Miriagou, V.
    Daikos, G. L.
    CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (08) : 951 - 957
  • [7] Treatment of infections caused by carbapenem-resistant Acinetobacter baumannii
    Zhang, Siqin
    Di, Lingfang
    Qi, Yan
    Qian, Xiang
    Wang, Siwei
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2024, 14
  • [8] Treatment Approaches for Carbapenem-Resistant Acinetobacter baumannii Infections
    Iovleva, Alina
    Fowler Jr, Vance G.
    Doi, Yohei
    DRUGS, 2025, 85 (01) : 21 - 40
  • [9] The Rise of Carbapenem-Resistant Acinetobacter baumannii
    Evans, Benjamin A.
    Hamouda, Ahmed
    Amyes, Sebastian G. B.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (02) : 223 - 238
  • [10] Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium
    Fernandez-Viladrich, P
    Corbella, X
    Corral, L
    Tuba, F
    Mateu, A
    CLINICAL INFECTIOUS DISEASES, 1999, 28 (04) : 916 - 917
12345